<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The effects of omega-3 on blood pressure and the relationship between serum visfatin level and blood pressure in patients with type II diabetes</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2012-03-10">10 Mar 2012</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mohammad</forename><surname>Javad</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hosseinzadeh</forename><surname>Atar</surname></persName>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hossein</forename><surname>Hajianfar</surname></persName>
							<email>hossein_hajian2005@yahoo.com</email>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">MSc</orgName>
								<orgName type="institution" key="instit2">Tehran University of Medical Sciences International Campus</orgName>
								<address>
									<settlement>Tehran</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ahmad</forename><surname>Bahonar</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">-General Practitioner</orgName>
								<orgName type="institution" key="instit2">Hypertension Research Center</orgName>
								<orgName type="institution" key="instit3">Isfahan Cardiovascular Research Institute</orgName>
								<orgName type="institution" key="instit4">Isfahan University of Medical Sciences</orgName>
								<address>
									<settlement>Isfahan</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Nutrition</orgName>
								<orgName type="institution">Tehran University of Medical Sciences International Campus</orgName>
								<address>
									<settlement>Tehran</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The effects of omega-3 on blood pressure and the relationship between serum visfatin level and blood pressure in patients with type II diabetes</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2012-03-10">10 Mar 2012</date>
						</imprint>
					</monogr>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T23:08+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Omega 3</term>
					<term>Visfatin</term>
					<term>Hypertension</term>
					<term>Type 2 Diabetes Mellitus</term>
				</keywords>
			</textClass>
			<abstract>
				<p>BACKGROUND: Hypertension is a condition normally detected in people with type II diabetes. It eventually leads to cardiovascular diseases in the patient. Visfatin is an adipocytokine which is secreted from adipose tissue and can affect the inflammatory reaction and also serum lipid levels. Additionally, omega-3 inhibits the accumulation of fat and formation of insulin resistance. The current study tried to investigate the effects of omega-3 on blood pressure compared to placebo and the relationship between serum visfatin levels and blood pressure. METHODS: A total number of 71 women with type II diabetes were randomly assigned to 2 groups to receive either omega-3 capsules or placebo capsules. In the first step, a questionnaire consisting age, height, weight, waist and hip circumferences, and systolic and diastolic blood pressure was filled out for each subject. Blood samples were then collected for laboratory tests. The next step was to conduct 8 weeks of intervention. All variables, except age, were measured again after the intervention. Hip circumference was considered as the maximum circumference of the buttocks. Waist circumference was measured by placing a tape horizontally across the abdomen at the end of a normal exhalation. Laboratory tests included the assessment of visfatin, glucose, and glycated hemoglobin (HbA1c) concentrations. Lipid profile, i.e. low density lipoprotein (LDL), high density lipoprotein (HDL), triglyceride (TG), and cholesterol, was also assessed. Using SPSS18, data obtained from the study was analyzed by a variety of appropriate statistical tests. RESULTS: There was a significant change in mean differences of systolic and diastolic blood pressure. Blood pressure showed a significant reduction in the omega-3 group compared to the placebo group. However, no significant changes were observed in systolic and diastolic blood pressure before and after the intervention (P &gt; 0.05). CONCLUSION: Based on the results of this study, a daily consumption of omega-3 is suggested for patients with type II diabetes.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>According to the World Health Organization (WHO), 150 million people are currently suffering from type II diabetes. This figure is predicted to be doubled by the year 2025. <ref type="bibr" target="#b0">1</ref> Today, the disease is detected in all age groups, including women and high risk groups. Mortality rates in diabetic individuals after adjusting for age is 1.5-2.5 times more than total population. <ref type="bibr" target="#b1">2</ref> Since in most cases, insulin resistance and diabetes are associated with obesity, obesity and overweight are considered as the major causes of diabetes and insulin resistance. <ref type="bibr" target="#b2">3</ref> In addition, hypertension is common in people with diabetes and its prevalence increases substantially over time. On the other hand, omega-3 intake may reduce blood pressure. <ref type="bibr" target="#b3">4</ref> Alpha lipoic acid reduces hypertension in people with type II diabetes. <ref type="bibr" target="#b4">5</ref> The prevalence of hypertension increases with age in both sexes. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7</ref> In 1989, one fourth of America's total population and one third of its adults suffered from high blood pressure. At the same time, hypertension developed in 30% of urban community adults in the East Mediterranean region. <ref type="bibr" target="#b7">8</ref> Visfatin is an adiponectin with insulin-like function 9,10 which was discovered in adipose tissues by <ref type="bibr">Fukuhara et al. in 2005. 11</ref> Omega 3 increases visfatin secretion in patients with type II diabetes. <ref type="bibr" target="#b11">12</ref> Obesity can lead to hyperplasia and hypertrophy of fat cells which secrete a variety of compounds with exert critical roles in the pathogenesis of diseases such as metabolic syndrome, hypertension, insulin resistance, and cardiovascular diseases. <ref type="bibr" target="#b12">13</ref> Omega-3 fatty acids have been demonstrated to reduce cholesterol, triglycerides, inflammation, cardiovascular diseases, and cancer. They may also prevent insulin resistance. Omega-3 fatty acids downregulate the expression of genes and hormones (such as leptin) involved in obesity. They also prevent the construction of omega-6 compounds. In type II diabetics, consumption of over 4 grams of eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) can increase serum glucose and reduce triglyceride. <ref type="bibr" target="#b13">14</ref> Visfatin is a regulator of fat metabolism 15 which has a direct relation with body mass index (BMI). <ref type="bibr" target="#b15">16</ref> Being directly relate with waist to hip ratio (WHR), serum visfatin level is higher in diabetics compared to normal healthy people. <ref type="bibr" target="#b10">11</ref> This study was designed to investigate whether omega-3 lowers blood pressure in diabetics and if there is any significant relationship between serum visfatin level and blood pressure in people with type II diabetes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head><p>This was a double-blind randomized controlled clinical study. The study population included 45-65 year-old female type II diabetes patients who referred to Charity Center of Diabetes in Isfahan, Iran. Using a formula and considering 15% additional samples, the sample size in each group was calculated as 39 in each group. Women were only included if they had at least a 5-year history of type II diabetes. Exclusion criteria were injecting insulin, having secondary complications of diabetes such as ophthalmic or renal complications and amputation, and having inflammatory diseases with C-reactive protein (CRP) levels of +++ or more. Finally, 39 patients in the omega-3 group and 34 subjects in the placebo group completed the study.</p><p>This study was approved by the Ethics Committee of Tehran University of Medical Sciences, Tehran, Iran. The participants were informed about the study procedure. They were then requested to sign the consent form. The subjects were randomly divided into two groups of omega-3 supplement recipients and placebo recipients. The omega-3 group received two omega-3 capsules containing 1,000 mg omega-3, 65% EPA (360 mg), and 35% DHA (240 mg) daily for 8 weeks. The placebo group received two placebo capsules containing 1 g of cornstarch for the same period.</p><p>The current study was performed in three phases. In the first phase, all patients filled out a questionnaire including age, height, weight, waist circumference, hip circumference, and systolic and diastolic blood pressure. Blood samples were also collected for blood tests. In the second stage, after 8 weeks of intervention, the same parameters were measured and blood samples were obtained again. Hip circumference was measured at the widest part. Waist circumference was also measured by a cord at the end of a normal exhalation. Blood pressure was measured by a mercury sphygmomanometer in a sitting position and after 10 minutes of rest.</p><p>Visfatin level was measured by standard kits using enzyme-linked immunosorbent assay (ELISA) method with a sensitivity of 30 pg/ml (Human Visfatin Kit, Adipogen Inc., South Korea). Both the examiner and the participants were blinded to the intervention. Blood sampling was conducted after 10-12 hours of fasting (10 cc in each time) before taking the anti-diabetic tablets.</p><p>All the tests were conducted automatically by Hitachi 911. Data was analyzed using SPSS18 (SPSS Inc., Chicago, IL, US). The Fisher's exact test was used to analyze qualitative data and student's t-test for quantitative data. Weight changes were analyzed by chi-square test while Pearson's correlation test was used to assess correlations. Moreover, paired t-test was used for comparing blood pressure changes before and after the intervention in both groups and independent t-test was used for comparing mean concentration changes between the two groups. To detect the correlations between variables, Pearson's regression analysis was used.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>The results showed no significant differences in the mean baseline values of age, socioeconomic characteristics such as educational status and occupation, health status, medication consumption and dietary intake between omega-3 and placebo groups. Therefore, these variables had probably no confounding effect. The mean age of omega-3 and placebo groups were 53.6 ± 4.3 and 53.9 ± 5.4 years, respectively. Student's t-test showed no significant differences in the mean ages of the two groups (P = 0.79). <ref type="table" target="#tab_0">Table 1</ref> presents the obtained data on BMI, weight, and systolic and diastolic blood pressure.</p><p>Although the comparison of values of before and after intervention showed no significant changes in the mean BMI within groups, there were significant differences in the mean BMI between groups. The same trend was observed for weight, as the changes after the intervention in each group were not significant compared to the value before the intervention but significant once comparing the two groups. The findings of this study revealed that the blood pressure of individuals who received placebo showed an upward trend during the intervention. However, omega-3 was able to reduce blood pressure in diabetics. Significant differences were thus detected between the two groups.</p><p>While at baseline, there were no significant changes in the mean systolic blood pressure within groups, the mean differences between groups were significant after the intervention (P = 0.003). Diastolic blood pressure had a similar trend. No significant differences within groups were observed before and after the study though, with a P of 0.002 the mean changes of DBP in omega-3 group significantly differed with what measured in placebo group. No significant changes were detected between systolic and diastolic blood pressure before and after the intervention <ref type="table">(Tables 2 and 3</ref>). </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>The current study evaluated the efficacy of omega-3 on blood pressure in type II diabetic patients. It also assessed the relationship between visfatin and blood pressure. The results showed that consumption of omega-3 was effective in people with type 2 diabetes since it increased visfatin <ref type="bibr" target="#b11">12</ref> and might have lowered blood pressure. There were no relationships between visfatin serum levels and systolic or diastolic blood pressure. Haider et al. <ref type="bibr" target="#b8">9</ref> and 2 studies by Dogru et al. <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18</ref> reported similar results.</p><p>Unlike the studies by Berndt et al. <ref type="bibr" target="#b18">19</ref> and Krzyzanowska et al. <ref type="bibr" target="#b19">20</ref> but similar to the obtained results by Fukuhara et al. <ref type="bibr" target="#b10">11</ref> and Chen et al., <ref type="bibr" target="#b10">11</ref> the current study indicated a significant positive relationship between the amount of abdominal obesity and serum levels of visfatin in patients with diabetes.</p><p>In addition, identical to our results, some previous studies showed no significant relationship between circulating visfatin levels and BMI. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b20">21</ref> On the contrary, the findings of the studies by Pagano et al.</p><p>on obese nondiabetics <ref type="bibr" target="#b21">22</ref> and Samara et al. on nondiabetic individuals with different weights <ref type="bibr" target="#b22">23</ref> showed an inverse relationship between BMI and circulating visfatin levels.</p><p>On the other hand, Chen et al. found a significant relationship between BMI and circulating visfatin levels in patients with diabetes. <ref type="bibr" target="#b8">9</ref> Generally, the amount of visceral fat or abdominal obesity and body fat, are determined by WHR and BMI, respectively. <ref type="bibr" target="#b18">19</ref> Some researches have revealed that consumption of omega-3 can burn more body fat and increase metabolism, causing weight loss in patients. <ref type="bibr" target="#b23">24</ref> In the present study, BMI, as measured by weight, decreased in patients taking omega-3 and increased in the placebo group. Kesavulu et al. proved that omega-3 supplements had beneficial effects on triglyceride, high-density lipoprotein cholesterol, lipid peroxidation, and antioxidant enzymes, which eventually lowered vascular complications in diabetics. <ref type="bibr" target="#b24">25</ref> In 1991, Malasanos and Stacpoole conducted a study on patients with type 2 diabetes. They suggested that EPA could lower the levels of serum lipids and lipoproteins, increase fluidity of cell membranes, and reduce platelet aggregation and blood pressure. <ref type="bibr" target="#b25">26</ref> Omega-3 intake has also been suggested to have a weight control effect on diabetics. <ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28</ref> In 2007, Dogru et al. conducted a study on 33 young patients who had recently been diagnosed with hypertension. It investigated the relationship between visfatin and blood pressure. To omit the possible confounding effects and relations between BMI and visfatin, patients with BMIs less than 25 were recruited to the study. However, no significant relationship was detected between serum visfatin level and blood pressure which was identical with the results achieved in this study. <ref type="bibr" target="#b17">18</ref> It has also been shown that the insulin receptor is associated with hypertension. <ref type="bibr" target="#b12">13</ref> Moreover, the insulin receptor and inflammation can be effective on the development of hypertension. <ref type="bibr" target="#b28">29</ref> However, our results did not support this role for visfatin.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Recommendations</head><p>Based on the positive effects of omega-3 on hypertension, daily consupmtion of omega-3 supplements for diabetics and individuals at high risk is highly recommended.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Table 2 .Table 3 .</head><label>23</label><figDesc>The relationship between visfatin and systolic (SBP) and diastolic blood pressure (DBP) at baseline Visfatin R The relationship between visfatin and systolic (SBP) and diastolic blood pressure (DBP) after the intervention Visfatin</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>Anthropometric data and visfatin level in the studied groups</figDesc><table><row><cell></cell><cell></cell><cell>Omega-3</cell><cell>Placebo</cell><cell>P</cell></row><row><cell></cell><cell>Before Intervention</cell><cell>27.7 ± 3.4</cell><cell>28 ± 3.8</cell><cell>0.76</cell></row><row><cell>Body mass index</cell><cell>After Intervention</cell><cell>27.4 ± 4.1</cell><cell>28.7 ± 4.4</cell><cell>0.19</cell></row><row><cell>(kg/m2)</cell><cell>Difference between After and Before</cell><cell>-0.31 ± 0.7</cell><cell>0.73 ± 1.2</cell><cell>&lt; 0.001</cell></row><row><cell></cell><cell>Before Intervention</cell><cell>69.6 ± 13.2</cell><cell>70.1 ± 11.3</cell><cell>0.84</cell></row><row><cell>Weight</cell><cell>After Intervention</cell><cell>68.8 ± 12.4</cell><cell>71.7 ± 12.8</cell><cell>0.33</cell></row><row><cell>(kg)</cell><cell>Difference between After and Before</cell><cell>-0.8 ± 1.8</cell><cell>1.5 ± 2.5</cell><cell>&lt; 0.001</cell></row><row><cell></cell><cell>Before Intervention</cell><cell>130 ± 19.2</cell><cell>118 ± 16.3</cell><cell>0.007</cell></row><row><cell>Systolic blood pressure</cell><cell>After Intervention</cell><cell>124.3 ± 13.7</cell><cell>124.1 ± 13.9</cell><cell>0.95</cell></row><row><cell>(mm Hg)</cell><cell>Difference between After and Before</cell><cell>-5.4 ± 17.6</cell><cell>6.2 ± 13.7</cell><cell>0.003</cell></row><row><cell></cell><cell>Before Intervention</cell><cell>82 ± 11.5</cell><cell>77 ± 10.7</cell><cell>0.08</cell></row><row><cell>Diastolic blood pressure</cell><cell>After Intervention</cell><cell>80.5 ± 7.6</cell><cell>82.6 ± 7.6</cell><cell>0.25</cell></row><row><cell>(mm Hg)</cell><cell>Difference between After and Before</cell><cell>-1.2 ± 8.4</cell><cell>5.6 ± 9.4</cell><cell>0.002</cell></row></table><note></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p>This article was derived from MSc thesis in the Isfahan University of Medical Sciences, No: IRCT138903164109N1.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of Interests</head><p>Authors have no conflict of interests.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Global Burden of Diabetes, 1995-2025: Prevalence, numerical estimates, and projections</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">E</forename><surname>Aubert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">H</forename><surname>Herman</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.21.9.1414</idno>
		<idno type="PMID">9727886</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1414" to="1431" />
			<date type="published" when="1998-09-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Associations between Two Single Nucleotide Polymorphisms of Adiponectin Gene and Coronary Artery Diseases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chan-Hee</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eun-Jung</forename><surname>Rhee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Se-Yeon</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hun-Sub</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Byung-Jin</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ki-Chul</forename><surname>Sung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bum-Su</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Won-Young</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jin-Ho</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ki-Won</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Man-Ho</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sun-Woo</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung-Roe</forename><surname>Park</surname></persName>
		</author>
		<idno type="DOI">10.1507/endocrj.k06-020</idno>
		<idno type="PMID">16926524</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/endocrj/53/5/53_5_671/_pdf" />
	</analytic>
	<monogr>
		<title level="j">Endocrine Journal</title>
		<title level="j" type="abbrev">Endocr J</title>
		<idno type="ISSN">0918-8959</idno>
		<idno type="ISSNe">1348-4540</idno>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="671" to="677" />
			<date type="published" when="2006" />
			<publisher>Japan Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">MORTALITY AMONG DIABETICS IN A NATIONAL SAMPLE</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joel</forename><forename type="middle">C</forename><surname>Kleinman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">P</forename><surname>Donahue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maureen</forename><forename type="middle">I</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fanchon</forename><forename type="middle">F</forename><surname>Finucane</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><forename type="middle">H</forename><surname>Madans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dwight</forename><forename type="middle">B</forename><surname>Brock</surname></persName>
		</author>
		<idno type="DOI">10.1093/oxfordjournals.aje.a114979</idno>
		<idno type="PMID">3394705</idno>
		<idno type="ark">ark:/67375/HXZ-MTZTMRHH-4</idno>
		<idno type="istexId">A4F6AECCDFBF359AA6873062FA1EAAAFF4B52DD3</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Epidemiology</title>
		<idno type="ISSN">0002-9262</idno>
		<idno type="ISSNe">1476-6256</idno>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="389" to="401" />
			<date type="published" when="1988-08" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title level="m" type="main">The Ultimate Omega-3 Diet: Maximize the Power of Omega-3s to Supercharge Your Health, Battle Inflammation, and Keep Your Mind Sharp</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Tribole</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2007" />
			<publisher>McGraw-Hill Professional</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Effect of anti oxidan Alfa lipoic acid on blood presur in patient with type 2 diabetes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Mazlom</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Ansari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Iranian Journal of Endocrinology and Metabolism</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="245" to="50" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title level="m" type="main">The heart</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">C</forename><surname>Schlat</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1994" />
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="190" to="192" />
			<pubPlace>New York: McGraw Hill</pubPlace>
		</imprint>
	</monogr>
	<note>th ed</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Hypertension among urban and rural Tongans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Finau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">A</forename><surname>Prior</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">E</forename><surname>Salmond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med J Aust</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="16" to="20" />
			<date type="published" when="1986" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title level="m" type="main">Prevention and control of cardiovascular diseases. Geneva: World Health Organization p</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Alwan</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1995" />
			<biblScope unit="page">21</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Elevated Plasma Level of Visfatin/Pre-B Cell Colony-Enhancing Factor in Patients with Type 2 Diabetes Mellitus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Miao-Pei</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fu-Mei</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dao-Ming</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Null-</forename><forename type="middle">R</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Han-Fen</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shyi-Jang</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yau-Jiunn</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2005-1475</idno>
		<idno type="PMID">16234302</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/91/1/295/10778482/jcem0295.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="295" to="299" />
			<date type="published" when="2006-01" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Increased Plasma Visfatin Concentrations in Morbidly Obese Subjects Are Reduced after Gastric Banding</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dominik</forename><forename type="middle">G</forename><surname>Haider</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karin</forename><surname>Schindler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Georg</forename><surname>Schaller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerhard</forename><surname>Prager</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Wolzt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bernhard</forename><surname>Ludvik</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2005-2248</idno>
		<idno type="PMID">16449335</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/91/4/1578/10779452/jcem1578.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1578" to="1581" />
			<date type="published" when="2006-04" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsunori</forename><surname>Fukuhara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Morihiro</forename><surname>Matsuda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masako</forename><surname>Nishizawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katsumori</forename><surname>Segawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masaki</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kae</forename><surname>Kishimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yasushi</forename><surname>Matsuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mirei</forename><surname>Murakami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoko</forename><surname>Ichisaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroko</forename><surname>Murakami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eijoro</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Toshiyuki</forename><surname>Takagi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Megumi</forename><surname>Akiyoshi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsuguteru</forename><surname>Ohtsubo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shinji</forename><surname>Kihara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shizuya</forename><surname>Yamashita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Makoto</forename><surname>Makishima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tohru</forename><surname>Funahashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shinya</forename><surname>Yamanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ryuji</forename><surname>Hiramatsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Matsuzawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Iichiro</forename><surname>Shimomura</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.ogx.0000172388.75302.e6</idno>
	</analytic>
	<monogr>
		<title level="j">Obstetrical &amp; Gynecological Survey</title>
		<title level="j" type="abbrev">Obstetrical &amp; Gynecological Survey</title>
		<idno type="ISSN">0029-7828</idno>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="523" to="524" />
			<date type="published" when="2005-08" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Common Polymorphisms in the Promoter of the Visfatin Gene (PBEF1) Influence Plasma Insulin Levels in a French-Canadian Population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">D</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Loredo-Osti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Lepage</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Faith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Fontaine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Desbiens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">J</forename><surname>Hudson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Bouchard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Gaudet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Perusse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M-C</forename><surname>Vohl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Engert</surname></persName>
		</author>
		<idno type="DOI">10.2337/db06-0189</idno>
		<idno type="PMID">17003359</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2896" to="2902" />
			<date type="published" when="2006-09-26" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerald</forename><forename type="middle">M</forename><surname>Reaven</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2003-030087</idno>
		<idno type="PMID">12788834</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/88/6/2399/9148857/jcem2399.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2399" to="2403" />
			<date type="published" when="2003-06" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title level="m" type="main">Modern Nutrition In Health And Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Shils</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Shike</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">C</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Caballero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">J</forename><surname>Cousins</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2006" />
			<publisher>Lippincott Williams &amp; Wilkins</publisher>
			<biblScope unit="page">1053</biblScope>
			<pubPlace>Philadelphia</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guang</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jessica</forename><surname>Bishop</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sammy</forename><surname>Khalili</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sudesh</forename><surname>Vasdev</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vicki</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Pace</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Donald</forename><surname>Fitzpatrick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edward</forename><surname>Randell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ya-Gang</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hongwei</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajcn/85.2.399</idno>
		<idno type="PMID">17284735</idno>
		<ptr type="open-access" target="https://academic.oup.com/ajcn/article-pdf/85/2/399/23891494/znu00207000399.pdf" />
	</analytic>
	<monogr>
		<title level="j">The American Journal of Clinical Nutrition</title>
		<idno type="ISSN">0002-9165</idno>
		<idno type="ISSNe">1938-3207</idno>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="399" to="404" />
			<date type="published" when="2007-02-01" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Human Visfatin Expression: Relationship to Insulin Sensitivity, Intramyocellular Lipids, and Inflammation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vijayalakshmi</forename><surname>Varma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aiwei</forename><surname>Yao-Borengasser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Neda</forename><surname>Rasouli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Angela</forename><forename type="middle">M</forename><surname>Bodles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bounleut</forename><surname>Phanavanh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mi-Jeong</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tasha</forename><surname>Starks</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leslie</forename><forename type="middle">M</forename><surname>Kern</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Horace</forename><forename type="middle">J</forename><surname>Spencer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">E</forename><surname>Mcgehee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">K</forename><surname>Fried</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Philip</forename><forename type="middle">A</forename><surname>Kern</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2006-1303</idno>
		<idno type="PMID">17090638</idno>
		<idno type="PMCID">PMC2893416</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/92/2/666/9053288/jcem0666.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="666" to="672" />
			<date type="published" when="2007-02" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Teoman</forename><surname>Dogru</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alper</forename><surname>Sonmez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ilker</forename><surname>Tasci</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ergun</forename><surname>Bozoglu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mahmut</forename><forename type="middle">Ilker</forename><surname>Yilmaz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Halil</forename><surname>Genc</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gokhan</forename><surname>Erdem</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mahmut</forename><surname>Gok</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Necati</forename><surname>Bingol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Selim</forename><surname>Kilic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Taner</forename><surname>Ozgurtas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sezin</forename><surname>Bingol</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2006.07.031</idno>
		<idno type="PMID">16956691</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes Research and Clinical Practice</title>
		<title level="j" type="abbrev">Diabetes Research and Clinical Practice</title>
		<idno type="ISSN">0168-8227</idno>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="24" to="29" />
			<date type="published" when="2007-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertension</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Dogru</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Sonmez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Tasci</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">I</forename><surname>Yilmaz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Erdem</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Erturk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Bingol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kilic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Ozgurtas</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.jhh.1002114</idno>
		<idno type="PMID">17096008</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/1002114.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Human Hypertension</title>
		<title level="j" type="abbrev">J Hum Hypertens</title>
		<idno type="ISSN">0950-9240</idno>
		<idno type="ISSNe">1476-5527</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="173" to="175" />
			<date type="published" when="2006-11-09" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Plasma Visfatin Concentrations and Fat Depot-Specific mRNA Expression in Humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Berndt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Kloting</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kralisch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Kovacs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Fasshauer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Schon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Stumvoll</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Bluher</surname></persName>
		</author>
		<idno type="DOI">10.2337/diabetes.54.10.2911</idno>
		<idno type="PMID">16186392</idno>
		<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/54/10/2911.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2911" to="2916" />
			<date type="published" when="2005-09-26" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Increased visfatin concentrations in women with gestational diabetes mellitus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katarzyna</forename><surname>Krzyzanowska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Walter</forename><surname>Krugluger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Friedrich</forename><surname>Mittermayer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rupa</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dominik</forename><surname>Haider</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nadja</forename><surname>Shnawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guntram</forename><surname>Schernthaner</surname></persName>
		</author>
		<idno type="DOI">10.1042/cs20050363</idno>
		<idno type="PMID">16489932</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/f37b/6889d8ee39fe2dbc5902f96e2bb8796a75f3.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical Science</title>
		<title level="j" type="abbrev">Clin. Sci.</title>
		<idno type="ISSN">0143-5221</idno>
		<idno type="ISSNe">1470-8736</idno>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="605" to="609" />
			<date type="published" when="2006-05-01" />
			<publisher>Portland Press Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sreedharan</forename><surname>Sandeep</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kaliyaperumal</forename><surname>Velmurugan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raj</forename><surname>Deepa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Viswanathan</forename><surname>Mohan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.metabol.2006.12.005</idno>
		<idno type="PMID">17379018</idno>
	</analytic>
	<monogr>
		<title level="j">Metabolism</title>
		<title level="j" type="abbrev">Metabolism</title>
		<idno type="ISSN">0026-0495</idno>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="565" to="570" />
			<date type="published" when="2007-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Reduced Plasma Visfatin/Pre-B Cell Colony-Enhancing Factor in Obesity Is Not Related to Insulin Resistance in Humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Claudio</forename><surname>Pagano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Catia</forename><surname>Pilon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Massimiliano</forename><surname>Olivieri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paola</forename><surname>Mason</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><surname>Fabris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><surname>Serra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gabriella</forename><surname>Milan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marco</forename><surname>Rossato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><surname>Federspil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberto</forename><surname>Vettor</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2006-0361</idno>
		<idno type="PMID">16720654</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/91/8/3165/10443223/jcem3165.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="3165" to="3170" />
			<date type="published" when="2006-08" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Visfatin, low-grade inflammation and body mass index (BMI)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anastasia</forename><surname>Samara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michèle</forename><surname>Pfister</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Berangère</forename><surname>Marie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sophie</forename><surname>Visvikis-Siest</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2265.2008.03205.x</idno>
		<idno type="PMID">18248642</idno>
		<idno type="ark">ark:/67375/WNG-J2FG33V6-8</idno>
		<idno type="istexId">80C99AC1626E8BACF3F639BCD2751FF04DB447ED</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Endocrinology</title>
		<idno type="ISSN">0300-0664</idno>
		<idno type="ISSNe">1365-2265</idno>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="568" to="574" />
			<date type="published" when="2008-10" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Docosahexaenoic Acid but Not Eicosapentaenoic Acid Lowers Ambulatory Blood Pressure and Heart Rate in Humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">A</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">Q</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">B</forename><surname>Puddey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Beilin</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.hyp.34.2.253</idno>
		<idno type="PMID">10454450</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.34.2.253" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="253" to="260" />
			<date type="published" when="1999-08-01" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">M</forename><surname>Kesavulu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">Kameswara</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Giri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Vijaya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Subramanyam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ch</forename><surname>Apparao</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0168-8227(01)00238-8</idno>
		<idno type="PMID">11378211</idno>
		<idno type="PII">S0168-8227(01)00238-8</idno>
		<idno type="ark">ark:/67375/6H6-KZB3XVLD-B</idno>
		<idno type="istexId">A19B99DBBBF2F4223581769EE42BFDB063319576</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes Research and Clinical Practice</title>
		<title level="j" type="abbrev">Diabetes Research and Clinical Practice</title>
		<idno type="ISSN">0168-8227</idno>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="33" to="39" />
			<date type="published" when="2001-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Biological Effects of -3 Fatty Acids in Diabetes Mellitus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">H</forename><surname>Malasanos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">W</forename><surname>Stacpoole</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.14.12.1160</idno>
		<idno type="PMID">1773702</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1160" to="1179" />
			<date type="published" when="1991-12-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Effect of Green Tea Supplementation on Insulin Sensitivity in Sprague−Dawley Rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Liang-Yi</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chi-Chang</forename><surname>Juan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Low-Tone</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yung-Pei</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lucy</forename><forename type="middle">Sun</forename><surname>Hwang</surname></persName>
		</author>
		<idno type="DOI">10.1021/jf030365d</idno>
		<idno type="PMID">14759162</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Agricultural and Food Chemistry</title>
		<title level="j" type="abbrev">J. Agric. Food Chem.</title>
		<idno type="ISSN">0021-8561</idno>
		<idno type="ISSNe">1520-5118</idno>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="643" to="648" />
			<date type="published" when="2004-02" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Epigallocatechin Gallate Supplementation Alleviates Diabetes in Rodents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Swen</forename><surname>Wolfram</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Raederstorff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mareike</forename><surname>Preller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ying</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sandra</forename><forename type="middle">R</forename><surname>Teixeira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christoph</forename><surname>Riegger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Weber</surname></persName>
		</author>
		<idno type="DOI">10.1093/jn/136.10.2512</idno>
		<idno type="PMID">16988119</idno>
		<ptr type="open-access" target="https://academic.oup.com/jn/article-pdf/136/10/2512/23897821/2512.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Nutrition</title>
		<idno type="ISSN">0022-3166</idno>
		<idno type="ISSNe">1541-6100</idno>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2512" to="2518" />
			<date type="published" when="2006-10-01" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Inflammation, endothelial dysfunction and the risk of high blood pressure: epidemiologic and biological evidence</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">E</forename><surname>Bautista</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.jhh.1001537</idno>
		<idno type="PMID">12692566</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/1001537.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Human Hypertension</title>
		<title level="j" type="abbrev">J Hum Hypertens</title>
		<idno type="ISSN">0950-9240</idno>
		<idno type="ISSNe">1476-5527</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="223" to="230" />
			<date type="published" when="2003-04" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
